Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kerr

Showing results (641-650 of 678) with videos related to

Pageof 68
Sort By:
Journal of Urban Health : Bulletin of the New York Academy of Medicine|May 6, 2005
Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug useCourtney L C Collins, Thomas Kerr, Laura M Kuyper, et al.
AIDS (London, England)|May 16, 2007
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAARTViviane D Lima, Josie Geller, David R Bangsberg, et al.
The International Journal on Drug Policy|September 5, 2024
Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, CanadaKelsey A Speed, JinCheol Choi, Guy Felicella, et al.
BMJ (Clinical Research Ed.)|May 2, 2009
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort studyEvan Wood, Thomas Kerr, Brandon D L Marshall, et al.
BMC Infectious Diseases|August 29, 2016
Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort studyKanna Hayashi, Evan Wood, Thomas Kerr, et al.
Archives of Pediatrics & Adolescent Medicine|January 6, 2010
Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian settingKate Shannon, Thomas Kerr, Brandon Marshall, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 28, 2016
Estimating State Transitions for Opioid Use DisordersEmanuel Krebs, Jeong E Min, Elizabeth Evans, et al.
Addiction (Abingdon, England)|March 25, 2010
Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug usersSasha Uhlmann, M-J Milloy, Thomas Kerr, et al.
AIDS Research and Therapy|May 26, 2006
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAARTViviane D Lima, Patricia Kretz, Anita Palepu, et al.
The Lancet. Public Health|April 22, 2018
Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling studyMichael A Irvine, Jane A Buxton, Michael Otterstatter, et al.
Pageof 68

Showing results (641-650 of 678) with videos related to

Sort By:
Pageof 68
Journal of Urban Health : Bulletin of the New York Academy of Medicine|May 6, 2005
Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug useCourtney L C Collins, Thomas Kerr, Laura M Kuyper, et al.
AIDS (London, England)|May 16, 2007
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAARTViviane D Lima, Josie Geller, David R Bangsberg, et al.
The International Journal on Drug Policy|September 5, 2024
Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, CanadaKelsey A Speed, JinCheol Choi, Guy Felicella, et al.
BMJ (Clinical Research Ed.)|May 2, 2009
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort studyEvan Wood, Thomas Kerr, Brandon D L Marshall, et al.
BMC Infectious Diseases|August 29, 2016
Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort studyKanna Hayashi, Evan Wood, Thomas Kerr, et al.
Archives of Pediatrics & Adolescent Medicine|January 6, 2010
Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian settingKate Shannon, Thomas Kerr, Brandon Marshall, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 28, 2016
Estimating State Transitions for Opioid Use DisordersEmanuel Krebs, Jeong E Min, Elizabeth Evans, et al.
Addiction (Abingdon, England)|March 25, 2010
Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug usersSasha Uhlmann, M-J Milloy, Thomas Kerr, et al.
AIDS Research and Therapy|May 26, 2006
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAARTViviane D Lima, Patricia Kretz, Anita Palepu, et al.
The Lancet. Public Health|April 22, 2018
Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling studyMichael A Irvine, Jane A Buxton, Michael Otterstatter, et al.
Pageof 68